This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1996 Nov;49(11):1223-4.

doi: 10.1016/s0895-4356(96)00208-9.

On the debate over methods for estimating the clinically important difference

D A Redelmeier¹, G H Guyatt, R S Goldstein

Affiliations

PMID: 8892488
DOI: 10.1016/s0895-4356(96)00208-9

Comparative Study

On the debate over methods for estimating the clinically important difference

D A Redelmeier et al. J Clin Epidemiol. 1996 Nov.

. 1996 Nov;49(11):1223-4.

doi: 10.1016/s0895-4356(96)00208-9.

Authors

D A Redelmeier¹, G H Guyatt, R S Goldstein

Affiliation

¹ Department of Medicine, University of Toronto, Ontario, Canada.

PMID: 8892488
DOI: 10.1016/s0895-4356(96)00208-9

No abstract available

PubMed Disclaimer

Comment on

Assessing the minimal important difference in symptoms: a comparison of two techniques.
Redelmeier DA, Guyatt GH, Goldstein RS. Redelmeier DA, et al. J Clin Epidemiol. 1996 Nov;49(11):1215-9. doi: 10.1016/s0895-4356(96)00206-5. J Clin Epidemiol. 1996. PMID: 8892486
The minimal important difference: who's to say what is important?
Wright JG. Wright JG. J Clin Epidemiol. 1996 Nov;49(11):1221-2. doi: 10.1016/s0895-4356(96)00207-7. J Clin Epidemiol. 1996. PMID: 8892487 No abstract available.

Similar articles

Assessing the minimal important difference in symptoms: a comparison of two techniques.
Redelmeier DA, Guyatt GH, Goldstein RS. Redelmeier DA, et al. J Clin Epidemiol. 1996 Nov;49(11):1215-9. doi: 10.1016/s0895-4356(96)00206-5. J Clin Epidemiol. 1996. PMID: 8892486
The minimal important difference: who's to say what is important?
Wright JG. Wright JG. J Clin Epidemiol. 1996 Nov;49(11):1221-2. doi: 10.1016/s0895-4356(96)00207-7. J Clin Epidemiol. 1996. PMID: 8892487 No abstract available.
Interpreting thresholds for a clinically significant change in health status in asthma and COPD.
Jones PW. Jones PW. Eur Respir J. 2002 Mar;19(3):398-404. doi: 10.1183/09031936.02.00063702. Eur Respir J. 2002. PMID: 11936514 Review.
Measuring inequities in health in Egypt.
Zaki A, Guirguis W. Zaki A, et al. East Mediterr Health J. 2001 Jan-Mar;7(1-2):287-90. East Mediterr Health J. 2001. PMID: 12596981 No abstract available.
Determinants of health: testing of a conceptual model.
Starfield B, Shi L. Starfield B, et al. Ann N Y Acad Sci. 1999;896:344-6. doi: 10.1111/j.1749-6632.1999.tb08136.x. Ann N Y Acad Sci. 1999. PMID: 10681917 Review. No abstract available.

See all similar articles

Cited by

Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study.
Devji T, Carrasco-Labra A, Qasim A, Phillips M, Johnston BC, Devasenapathy N, Zeraatkar D, Bhatt M, Jin X, Brignardello-Petersen R, Urquhart O, Foroutan F, Schandelmaier S, Pardo-Hernandez H, Vernooij RW, Huang H, Rizwan Y, Siemieniuk R, Lytvyn L, Patrick DL, Ebrahim S, Furukawa T, Nesrallah G, Schünemann HJ, Bhandari M, Thabane L, Guyatt GH. Devji T, et al. BMJ. 2020 Jun 4;369:m1714. doi: 10.1136/bmj.m1714. BMJ. 2020. PMID: 32499297 Free PMC article.
Health status measurement in chronic obstructive pulmonary disease.
Jones PW. Jones PW. Thorax. 2001 Nov;56(11):880-7. doi: 10.1136/thorax.56.11.880. Thorax. 2001. PMID: 11641515 Free PMC article. Review.
Clinical Significance Unveiled: Understanding the Meaning of FACE-Q Skin Cancer Scores for Improved Patient Care.
Veldhuizen IJ, Dusza SW, Kuo A, Aleisa A, Blue E, Adhikari S, Nadir U, Le K, Kazemi S, Sutton AV, Nijhawan RI, Eisen DB, Rossi AM, Srivastava D, Wysong A, Nehal KS, Klassen AF, Lee EH. Veldhuizen IJ, et al. Psychooncology. 2024 Oct;33(10):e70009. doi: 10.1002/pon.70009. Psychooncology. 2024. PMID: 39420453
How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.
Brozek JL, Guyatt GH, Schünemann HJ. Brozek JL, et al. Health Qual Life Outcomes. 2006 Sep 27;4:69. doi: 10.1186/1477-7525-4-69. Health Qual Life Outcomes. 2006. PMID: 17005037 Free PMC article.
Sample size determination for cost-effectiveness trials.
Willan AR. Willan AR. Pharmacoeconomics. 2011 Nov;29(11):933-49. doi: 10.2165/11587130-000000000-00000. Pharmacoeconomics. 2011. PMID: 21988292 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science